{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:21:07Z","timestamp":1777983667552,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.accpm.2026.101768","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:40:55Z","timestamp":1770424855000},"page":"101768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linezolid use in postoperative central nervous system infections: a pharmacokinetic simulation-based approach for critically ill patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Charles","family":"Baulier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Giry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Loz\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Lozouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Glenisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoubir","family":"Djerada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e9vin","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Duflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.accpm.2026.101768_bib0005","first-page":"688","article-title":"Ventriculostomy-related infections: a critical review of the literature","volume":"62","author":"Lozier","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.accpm.2026.101768_bib0010","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1086\/324492","article-title":"Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients","volume":"33","author":"Lyke","year":"2001","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.accpm.2026.101768_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12879-014-0712-z","article-title":"A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections","volume":"15","author":"Ramanan","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.accpm.2026.101768_bib0020","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious diseases society of america\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.accpm.2026.101768_bib0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dky543","article-title":"CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study","volume":"74","author":"Blassmann","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0030","doi-asserted-by":"crossref","first-page":"e01998","DOI":"10.1128\/AAC.01998-20","article-title":"A systematic review of studies reporting antibiotic pharmacokinetic data in the cerebrospinal fluid of critically ill patients with uninflamed meninges","volume":"65","author":"Kumta","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0035","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.accpm.2026.101768_bib0040","series-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2022","year":"2023"},{"key":"10.1016\/j.accpm.2026.101768_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijantimicag.2003.11.003","article-title":"Oxazolidinones: activity, mode of action, and mechanism of resistance","volume":"23","author":"Bozdogan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2026.101768_bib0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dks464","article-title":"National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience","volume":"68","author":"Carbonne","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0055","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current -lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.accpm.2026.101768_bib0060","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/cid\/ciac506","article-title":"Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis","volume":"75","author":"Pai Mangalore","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.accpm.2026.101768_bib0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2026.101768_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000940","article-title":"Therapeutic drug monitoring of antibiotics: defining the therapeutic range","volume":"44","author":"Abdul-Aziz","year":"2022","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.accpm.2026.101768_bib0075","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003088-200342150-00007","article-title":"Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme","volume":"42","author":"Rayner","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.accpm.2026.101768_bib0080","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1093\/jac\/dkg248","article-title":"Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections","volume":"51","author":"MacGowan","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0085","first-page":"15","article-title":"Comparative effectiveness and safety of vancomycin versus linezolid for the treatment of central nervous system infections: a meta-analysis","author":"Zhou","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.accpm.2026.101768_bib0090","author":"Baron"},{"key":"10.1016\/j.accpm.2026.101768_bib0095","unstructured":"Team Rs. RStudio: Integrated Development Environment for R [Internet]. 2024. Available from: https:\/\/posit.co\/products\/open-source\/rstudio\/ n.d."},{"key":"10.1016\/j.accpm.2026.101768_bib0100","unstructured":"R Core Team (2024). _R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria. <https:\/\/www.R-project.org\/>. n.d."},{"key":"10.1016\/j.accpm.2026.101768_bib0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid","volume":"310","author":"Reiber","year":"2001","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.accpm.2026.101768_bib0110","volume":"2024","author":"Dahyot-Fizelier","year":"2025","journal-title":"CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicenter Pharmacokinetics and Pharmacodynamics Population Study"},{"key":"10.1016\/j.accpm.2026.101768_bib0115","first-page":"13","article-title":"Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.accpm.2026.101768_bib0120","series-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters [Internet]","year":"2024"},{"key":"10.1016\/j.accpm.2026.101768_bib0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijantimicag.2014.07.001","article-title":"Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections","volume":"44","author":"Luque","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2026.101768_bib0130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.xphs.2022.12.016","article-title":"Population pharmacokinetics and dosing regimen optimization of linezolid in cerebrospinal fluid and plasma of Post-operative neurosurgical patients","volume":"112","author":"Li","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.accpm.2026.101768_bib0135","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12028-024-02144-6","article-title":"Augmented renal clearance: prevalence, risk factors and underlying mechanism in critically ill patients with subarachnoid hemorrhage","volume":"42","author":"de Courson","year":"2025","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.accpm.2026.101768_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00228-020-02978-x","article-title":"Prolonged infusion of linezolid is associated with improved pharmacokinetic\/pharmacodynamic (PK\/PD) profiles in patients with external ventricular drains","volume":"77","author":"Zhao","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.accpm.2026.101768_bib0145","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2147\/DDDT.S168757","article-title":"Pharmacokinetics and pharmacodynamics of linezolid in plasma\/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation","volume":"12","author":"Wu","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.accpm.2026.101768_bib0150","first-page":"296","article-title":"Continuous versus intermittent linezolid infusion for critically ill patients with hospital-acquired and ventilator-associated pneumonia: efficacy and safety challenges","volume":"15","author":"Abou Warda","year":"2022","journal-title":"Pharm Basel Switz"},{"key":"10.1016\/j.accpm.2026.101768_bib0155","first-page":"1118","article-title":"Efficacy and safety of continuous vs intermittent linezolid infusion in critically ill patients with septic shock","volume":"28","author":"Albadry","year":"2024","journal-title":"Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med"},{"key":"10.1016\/j.accpm.2026.101768_bib0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2010.02.019","article-title":"Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction","volume":"36","author":"Matsumoto","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2026.101768_bib0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2014.05.010","article-title":"Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients","volume":"44","author":"Matsumoto","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2026.101768_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106572","article-title":"Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients","volume":"59","author":"Wicha","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.accpm.2026.101768_bib0175","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s10143-025-03891-6","article-title":"Linezolid use in post-neurosurgical central nervous system infections: a systematic review","volume":"48","author":"Baulier","year":"2025","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.accpm.2026.101768_bib0180","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","article-title":"Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients","volume":"50","author":"Myrianthefs","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-017-0588-3","article-title":"Antibiotic distribution into cerebrospinal fluid: can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections?","volume":"57","author":"Kumta","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.accpm.2026.101768_bib0190","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.CCM.0000168206.59873.80","article-title":"Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2026.101768_bib0195","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.01468-05","article-title":"Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis","volume":"50","author":"Buerger","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0200","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2026.101768_bib0205","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1128\/AAC.00356-16","article-title":"Predictors of inadequate linezolid concentrations after standard dosing in critically ill patients","volume":"60","author":"Taubert","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0210","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.2174\/138920111798808446","article-title":"ARC--augmented renal clearance","volume":"12","author":"Udy","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.accpm.2026.101768_bib0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/AAC.00515-06","article-title":"Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains","volume":"51","author":"Beer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.accpm.2026.101768_bib0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/00365548.2011.600327","article-title":"Pharmacokinetics and protein binding of linezolid in cerebrospinal fluid and serum in a case of post-neurosurgical bacterial meningitis","volume":"43","author":"Tsuji","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.accpm.2026.101768_bib0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1345\/aph.1H029","article-title":"Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis","volume":"40","author":"Boak","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.accpm.2026.101768_bib0230","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.accpm.2026.101768_bib0235","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/AAC.37.7.1518","article-title":"Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges","volume":"37","author":"Nau","year":"1993","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556826000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556826000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:25:38Z","timestamp":1777980338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556826000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2352556826000263"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2026.101768","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linezolid use in postoperative central nervous system infections: a pharmacokinetic simulation-based approach for critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2026.101768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et de R\u00e9animation (SFAR). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101768"}}